Research Topics
| Otis W BrawleySummaryAffiliation: Emory University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Cancer screening in theory and in practiceOtis W Brawley
Georgia Cancer Center, Glenn Memorial Bldg, 69 Jesse Hill Jr Drive, Atlanta, GA 30303, USA
J Clin Oncol 23:293-300. 2005..A screening test is done on asymptomatic individuals who receive the test principally because they are of the age or sex at risk for the cancer. A diagnostic test is done on an individual because of clinical suspicion of disease...
Hormonal prevention of prostate cancerOtis W Brawley
Professor of Medicine, Oncology and Epidemiology, The Winship Cancer Institute, Emory University, Atlanta, GA, USA
Urol Oncol 21:67-72. 2003..A placebo controlled randomized trial using finasteride, an inhibitor of 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone, is ongoing. The endpoint of this trial is reduction of prostate cancer incidence...
Prostate cancer screening: clinical applications and challengesOtis W Brawley
Winship Cancer Institute, Emory University School of Medicine and Emory Rollins School of Public Health, 69 Jesse Hill Jr Drive, Atlanta, GA 30303, USA
Urol Oncol 22:353-7. 2004....
Population categorization and cancer statisticsOtis W Brawley
Winship Cancer Institute Emory University, Atlanta, Georgia, USA
Cancer Metastasis Rev 22:11-9. 2003..While a specific gene or series of genes can be conserved within a relatively closed population, genetic variation within a given population or race is significant...
Introduction: Cancer and health disparitiesOtis W Brawley
Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
Cancer Metastasis Rev 22:7-9. 2003
Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American populationSheryl G A Gabram
Georgia Cancer Center for Excellence at Grady Health System, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Cancer 113:602-7. 2008..They then assessed the effectiveness of these outreach initiatives and internal patient navigation on stage of diagnosis...
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GAMary Jo Lund
Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, USA
Breast Cancer Res Treat 113:357-70. 2009..This study examines association of the ER/PR/HER2 subtypes with race and breast cancer survival...
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screeningRobert A Smith
Cancer Control Science Department, American Cancer Society, Atlanta, GA 30303, USA
CA Cancer J Clin 60:99-119. 2010....
Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screeningRobert A Smith
Director of Cancer Screening, Cancer Control Science Department, American Cancer Society, Atlanta, GA, USA
CA Cancer J Clin 61:8-30. 2011..The latest data on the utilization of cancer screening from the National Health Interview Survey is described, as well as several recent reports on the role of health care professionals in adult utilization of cancer screening...
Characteristics and treatment modalities for African American women diagnosed with stage III breast cancerMonica Rizzo
Avon Comprehensive Breast Cancer Center at Grady, Emory University, Atlanta, Georgia, USA
Cancer 115:3009-15. 2009..The aim of this study was to correlate age, receptor status, nuclear grade, and differences in treatment modalities for stage III breast cancer in an inner-city hospital serving a large AA population...
Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screeningRobert A Smith
Cancer Control Science Department, American Cancer Society, Atlanta, GA 30303, USA
CA Cancer J Clin 59:27-41. 2009....
Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncologyTimothy V Johnson
Department of Urology, School of Medicine, Emory University, Atlanta, GA 30322, USA
Psychooncology 21:351-6. 2012..Therefore, we sought to characterize the distribution of suicides in order to potentially identify a clinically important window of peak suicide risk...
A black-white comparison of the quality of stage-specific colon cancer treatmentJamillah Berry
Prevention Research Center, Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, Georgia 30310 1495, USA
Cancer 116:713-22. 2010..However, an Institute of Medicine report found that blacks received lower quality care than whites after controlling for health insurance, income, and disease severity...
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysisAshesh B Jani
Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
Am J Clin Oncol 31:375-8. 2008..The objective of this investigation was to use the Surveillance, Epidemiology, and End Results (SEER) registry to examine time trends in age and grade...
Screening for prostate cancerOtis W Brawley
American Cancer Society, Atlanta, GA, USA
CA Cancer J Clin 59:264-73. 2009..Men undergoing screening for prostate cancer may reduce their risk of prostate cancer with finasteride...
Racial disparities in colorectal cancerJohn Kauh
Department of Hematology and Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia, USA
Curr Probl Cancer 31:123-33. 2007
Prostate cancer epidemiology in the United StatesOtis W Brawley
Department of Hematology and Medical Oncology, Emory University, American Cancer Society, Atlanta, GA, USA
World J Urol 30:195-200. 2012..It is the most commonly diagnosed non-skin cancer and the second leading cause of cancer death. The American Cancer Society estimates that in 2011, 240,890 men were diagnosed with prostate cancer and 33,720 men died of it...
Myeloma and race: a review of the literatureMichael Benjamin
Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
Cancer Metastasis Rev 22:87-93. 2003..Factors such as socioeconomic status, dietary preferences, vitamin intake, alcohol and tobacco use, either lack a consensus finding, or may not play a role in explaining the increased myeloma morbidity and mortality in blacks...
Toward a better understanding of race and cancerOtis W Brawley
Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia 30303, USA
Clin Cancer Res 16:5920-2. 2010..Advances in immunohistochemistry and the appreciation of breast cancer subtypes are enabling investigators to study the distribution of these subtypes among populations...
Examining racial differences in diffuse large B-cell lymphoma presentation and survivalChristopher R Flowers
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
Leuk Lymphoma 54:268-76. 2013..61, p = 0.01). Future studies should examine biological differences that may underlie the observed racial differences in presentation and outcome...
Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United StatesChristopher R Flowers
Department of Hematology Oncology, School of Medicine, Emory University, Atlanta, GA 30322, USA
Cancer Epidemiol Biomarkers Prev 21:1520-30. 2012..In 2002, randomized trials changed this standard by showing that adding rituximab immunotherapy to CHOP improved survival. However, how these results influenced chemoimmunotherapy adoption in clinical practice remains unclear...
The American Cancer Society and the American Health Care SystemOtis W Brawley
F A C P, American Cancer Society, Atlanta, Georgia 30303, USA
Oncologist 16:920-5. 2011..We are committed proponents of the rational, evidence-based use of health care to avoid the wasteful and inefficient rationing of health care...
Prostate cancer in black and white AmericansSreekanth Reddy
Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
Cancer Metastasis Rev 22:83-6. 2003..Several studies show that there are racial differences in patterns of care in the US and it has been hypothesized that this contributes to some of the racial disparity in survival after diagnosis...
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results programTimothy V Johnson
Department of Urology, School of Medicine, Emory University, Atlanta, GA 30322, USA
Cancer 116:2960-6. 2010..Therefore, they assessed the frequency of inguinal lymphadenectomy and the impact of dissection extent on survival using the Surveillance, Epidemiology, and End Results (SEER) database...
Cancer screeningOtis W Brawley
Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
Semin Oncol 31:47-53. 2004..Many available screening tests have tremendous potential in terms of benefit, but have yet to be fully assessed. At the minimum, patients should be informed of what is known, what is not known, and what is believed about these tests...
Oropharyngeal cancer, race, and the human papillomavirusOtis W Brawley
American Cancer Society, Atlanta, GA 30303, USA
Cancer Prev Res (Phila) 2:769-72. 2009..This discussion is expanded to a more general consideration of biological and nonbiological (e.g., socioeconomic and cultural) factors affecting racial disparities in disease...
Prostate cancer and raceOtis W Brawley
Department of Hematology and Oncology, Emory School of Medicine, Emory University, Atlanta, Georgia, USA
Curr Probl Cancer 31:211-25. 2007
Racial differences in the incidence and outcomes for patients with hematological malignanciesChristopher R Flowers
Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
Curr Probl Cancer 31:182-201. 2007
National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell diseaseOtis W Brawley
American Cancer Society, 250 Williams Street, Atlanta, GA 30303, USA
Ann Intern Med 148:932-8. 2008
Racial disparities in lung cancerMitchel Berger
Emory University, Atlanta, Georgia, USA
Curr Probl Cancer 31:202-10. 2007
Cancer and disparities in health: perspectives on health statistics and research questionsOtis W Brawley
American Cancer Society, Atlanta, Georgia 30303, USA
Cancer 113:1744-54. 2008
High prevalence of triple-negative tumors in an urban cancer centerMary Jo B Lund
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, USA
Cancer 113:608-15. 2008..In the current study, the authors investigated breast cancer subgroups among patients in an urban cancer center serving a multiracial, low socioeconomic population...
Nonmedical factors in treatment selectionOtis W Brawley
Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Road, NE, Suite B4100, Atlanta, GA 30322, USA
Urol Clin North Am 30:331-5. 2003..These factors, along with the absence of a clearly superior therapy, account, at least in part, for the tremendous variance in patterns of care by age, geography, race and education...
Race and disparities in healthOtis W Brawley
Hematology and Oncology, Emory School of Medicine, Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
Curr Probl Cancer 31:114-22. 2007
Chemoprevention in prostate cancerVasileios Assikis
Winship Cancer Institute at Emory University, Atlanta, GA, USA
Curr Probl Cancer 28:218-30. 2004
Some perspective on black-white cancer statisticsOtis W Brawley
CA Cancer J Clin 52:322-5. 2002
Survival of blacks and whites after a cancer diagnosisPeter B Bach
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
JAMA 287:2106-13. 2002..Differences in treatment, stage at presentation, and mortality from other diseases should represent the primary targets of research and interventions designed to reduce disparities in cancer outcomes...
Informed consent for prostate-specific antigen-based screeningOtis W Brawley
Urology 61:10-2. 2003
Are racial and ethnic minorities less willing to participate in health research?David Wendler
Department of Clinical Bioethics, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
PLoS Med 3:e19. 2006..It is widely claimed that racial and ethnic minorities, especially in the US, are less willing than non-minority individuals to participate in health research. Yet, there is a paucity of empirical data to substantiate this claim...
Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatmentOtis W Brawley
J Clin Oncol 24:332-3. 2006
The worldwide epidemiology of prostate cancer: perspectives from autopsy studiesGabriel P Haas
Department of Urology, SUNY Upstate Medical University, Syracuse, New York 13210, USA
Can J Urol 15:3866-71. 2008..Prostate cancer is the most frequently diagnosed non-skin cancer in the United States and the third leading cause of cancer deaths. International trends in the incidence, mortality and prevalence of prostate cancer are assessed...
Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results databaseWilliam F Anderson
NCI Division of Cancer Prevention, EPN, Bethesda, MD 20892 7317, USA
Breast Cancer Res Treat 76:27-36. 2002..Researchers question whether estrogen receptor alpha-negative (ERN) and -positive (ERP) represent different stages of one disease or different breast cancer types...
Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004Shamim M Baker
Urology 65:1259-62. 2005
New ACS chief medical officer. Interview by Carrie PrintzOtis W Brawley
Cancer 113:1499. 2008
Colorectal carcinoma in black and white raceWilliam F Anderson
National Cancer Institute/Division of Cancer Prevention/Gastrointestinal Cancer and Other Cancers Research Group, Bethesda, Maryland, USA
Cancer Metastasis Rev 22:67-82. 2003..Racial variations demonstrate the need for a more comprehensive understanding of colorectal carcinogenesis, epidemiology, and colorectal screening patterns for low- and high-risk populations...
Disaggregating the effects of race and poverty on breast cancer outcomesOtis W Brawley
J Natl Cancer Inst 94:471-3. 2002
The study of accrual to clinical trials: can we learn from studying who enters our studies?Otis W Brawley
J Clin Oncol 22:2039-40. 2004
